Real world chart review study of adverse events of special interest (AESI) Management in patients taking tyrosine kinase inhibitors (TKis) to treat metastatic renal cell carcinoma (mRCC) Srinivas, S., Stein, D., Teltsch, D., Tao, S., Chen, C., Cisar, L., Ramaswamy, K. WILEY-BLACKWELL. 2015: 20–21

View details for Web of Science ID 000366284900041